Research on the Construction of a Prognostic Model for COPD Complicated With Sarcopenic Obesity Based on Bioelectrical Impedance Phase Angle Technology

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This study aims to explore the diagnosis, impact, and prognostic factors of COPD complicated with sarcopenic obesity using multi-segment bioelectrical impedance phase angle technology. It seeks to clarify the diagnostic value and efficacy of body composition analysis in specific populations, analyze the relationship between phase angle and COPD severity as well as quality of life, investigate its predictive role for adverse outcomes, and reveal the effects of inflammation and metabolic disorders in sarcopenic obesity. The goal is to provide a basis for early screening and precise intervention to improve patient prognosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Age over 65 years;

• Ability to complete physical activity assessments and pulmonary function tests;

• Complete medical records, willingness to adhere to follow-up arrangements, and provision of adverse event reports via telephone or outpatient visits, with signed informed consent;

• COPD diagnosis based on the American Thoracic Society (ATS)/European Respiratory Society (ERS) GOLD definition, with a post-bronchodilator FEV1/FVC ratio \< 0.70, current or former smokers with a smoking history of ≥10 pack-years.

Locations
Other Locations
China
Huadong hospital, Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Ting Zhao, MD, PhD
65375201@qq.com
+86-21-62483180
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2028-06
Participants
Target number of participants: 200
Treatments
COPD with sarcopenic obesity
COPD with sarcopenic obesity based on Bioelectrical Impedance Phase Angle Technology by the enrollment
COPD without sarcopenic obesity
COPD without sarcopenic obesity based on Bioelectrical Impedance Phase Angle Technology by the enrollment
Sponsors
Leads: Fudan University

This content was sourced from clinicaltrials.gov